Please login to the form below

Not currently logged in

patient safety

This page shows the latest patient safety news and features for those working in and with pharma, biotech and healthcare.

bluebird bio temporarily suspends trials of sickle cell gene therapy LentiGlobin

bluebird bio temporarily suspends trials of sickle cell gene therapy LentiGlobin

Another SUSAR of myelodysplastic syndrome (MDS) in a patient from group C of HGB-206 was also reported last week, which bluebird also said it is currently investigating. ... The safety of every patient who has participated in our studies or is treated

Latest news

More from news
Approximately 71 fully matching, plus 241 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 40 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 21 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...